BIOMAT Database Logo BIOMAT Database Logo

Hydralazine is involved in tele-methylhistamine metabolism by inhibiting monoamine oxidase B in pregnancy-associated hypertensive mice. 2017

Shohei Kawasaki, and Koichiro Kako, and Yusuke Nagashima, and Akihiko Kanou, and Junji Ishida, and Akiyoshi Fukamizu
Graduate School of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan.

Hypertensive disorders of pregnancy globally affect 6-8% of gestation and remain a major cause of both foetal and maternal morbidity and mortality. However, the antihypertensive medications for the patients of this disease are strictly limited due to the teratogenic potentials. Here, we found that tele-methylhistamine (tMH) increased in response to the administration of hydralazine (Hdz), a vasodilative agent, in the pregnancy-associated hypertensive (PAH) mice. Hdz abrogated the degradation of tMH catalyzed by monoamine oxidase B (MAO-B) in vitro. These results suggested that Hdz inhibited the MAO-B activity and consequently tMH increased in the maternal circulation of PAH mice.

UI MeSH Term Description Entries
D008761 Methylhistamines Histamine substituted in any position with one or more methyl groups. Many of these are agonists for the H1, H2, or both histamine receptors.
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006830 Hydralazine A direct-acting vasodilator that is used as an antihypertensive agent. Hydrallazin,Apresoline,Apressin,Apressoline,Hydralazine Hydrochloride,Hydralazine mono-Hydrochloride,Hydrazinophthalazine,Nepresol,Hydralazine mono Hydrochloride,Hydrochloride, Hydralazine,mono-Hydrochloride, Hydralazine
D000588 Amines A group of compounds derived from ammonia by substituting organic radicals for the hydrogens. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

Shohei Kawasaki, and Koichiro Kako, and Yusuke Nagashima, and Akihiko Kanou, and Junji Ishida, and Akiyoshi Fukamizu
Tele-methylhistamine oxidation by type B monoamine oxidase.
March 1979, The Journal of pharmacology and experimental therapeutics,
Shohei Kawasaki, and Koichiro Kako, and Yusuke Nagashima, and Akihiko Kanou, and Junji Ishida, and Akiyoshi Fukamizu
1,4-Methylhistamine is a specific substrate for type B monoamine oxidase.
June 1979, Life sciences,
Shohei Kawasaki, and Koichiro Kako, and Yusuke Nagashima, and Akihiko Kanou, and Junji Ishida, and Akiyoshi Fukamizu
Tele-Methylhistamine is a specific MAO B substrate in man.
January 1980, Psychopharmacology,
Shohei Kawasaki, and Koichiro Kako, and Yusuke Nagashima, and Akihiko Kanou, and Junji Ishida, and Akiyoshi Fukamizu
HYPERTENSIVE CRISIS ASSOCIATED WITH MONOAMINE-OXIDASE INHIBITORS.
March 1964, Lancet (London, England),
Shohei Kawasaki, and Koichiro Kako, and Yusuke Nagashima, and Akihiko Kanou, and Junji Ishida, and Akiyoshi Fukamizu
Striatal dopamine metabolism in monoamine oxidase B-deficient mice: a brain dialysis study.
December 1999, Journal of neurochemistry,
Shohei Kawasaki, and Koichiro Kako, and Yusuke Nagashima, and Akihiko Kanou, and Junji Ishida, and Akiyoshi Fukamizu
Variable action of monoamine oxidase-inhibiting hydrazines on serotonin metabolism.
March 1963, Nature,
Shohei Kawasaki, and Koichiro Kako, and Yusuke Nagashima, and Akihiko Kanou, and Junji Ishida, and Akiyoshi Fukamizu
Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase.
April 2012, Journal of neural transmission (Vienna, Austria : 1996),
Shohei Kawasaki, and Koichiro Kako, and Yusuke Nagashima, and Akihiko Kanou, and Junji Ishida, and Akiyoshi Fukamizu
In vitro metabolism of citalopram by monoamine oxidase B in human blood.
February 2001, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
Shohei Kawasaki, and Koichiro Kako, and Yusuke Nagashima, and Akihiko Kanou, and Junji Ishida, and Akiyoshi Fukamizu
Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B.
July 1985, FEBS letters,
Shohei Kawasaki, and Koichiro Kako, and Yusuke Nagashima, and Akihiko Kanou, and Junji Ishida, and Akiyoshi Fukamizu
Circulating monoamine oxidase B and phenolsulfotransferase activities in essential hypertensive patients.
January 1988, Clinical and experimental hypertension. Part A, Theory and practice,
Copied contents to your clipboard!